NBCF Has Announced a Landmark $25 Million Investment
Julie Ince-Demetriou, Executive Director of Research at the National Breast Cancer Foundation, shared Cleola Anderiesz’s post on LinkedIn:
“I am both excited and proud to share the National Breast Cancer Foundation announcement released today.
‘Historic $25 Million Collaborative Research Accelerator Grant Powers National Push to Halve Breast Cancer Deaths’ ”
Quoting Cleola Anderiesz’s, Chief Executive Officer at National Breast Cancer Foundation post:
” “Historic $25 Million Grant Powers National Push to Halve Breast Cancer Deaths”
I am proud to announce that today, the National Breast Cancer Foundation (NBCF) has announced a landmark $25 million investment – the largest in its history – awarding its first Collaborative Research Accelerator (CRA) Grant to an exceptional local and international collaboration led by the Garvan Institute of Medical Research to tackle one of breast cancer’s most complex challenges – how to stop the recurrence of breast cancer.
The AllClear research program will be funded over five years and is a collaboration of nearly 60 researchers across seven leading research institutes and organisations.
This includes Breast Cancer Trials, the University of Sydney, the University of Newcastle, together with world-renowned international partners including Yale School of Medicine and Washington University School of Medicine in St. Louis, and 11 hospitals across NSW. , with the ultimate goal to halve deaths from breast cancer.
NBCF’s inaugural CRA represents a transformative leap forward in breast cancer research.
More than 21,000 people will be diagnosed with breast cancer each year and around 3,300 Australians still die from the disease annually. For some of these people breast cancer cells can hide quietly in the body reappearing years or even decades later. Around 15% of people will experience a recurrence of their breast cancer within 10 years, and this return can be life threatening.
More than just funding – it’s a strategic catalyst to support long-term research, high-impact collaboration, and deliver meaningful outcomes. It empowers researchers to work together at scale, driving innovation and accelerating progress toward NBCF’s vision of Zero Deaths from breast cancer.
You can find out more about the CRA Grant and the groundbreaking ‘AllClear’ program, here.”
Read more about Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023